Primary aldosteronism is present in 10% of individuals with hypertension and accounts for ~20% of cases of resistant hypertension. 1,2 Therefore, diagnosis and treatment of this condition is important with more stringent guidelines for blood pressure control. 3 After biochemical confirmation of primary aldosteronism, determining the subtype of disease is critical to provide appropriate treatment options. 4 The 2 most common subtypes of primary aldosteronism are bilateral adrenal hyperplasia (~60% of cases) and aldosterone-producing adenomas (APAs) (~35% of cases). 5, 6 Patients with an APA or unilateral hyperplasia may prefer laparoscopic adrenalectomy, which can lower blood pressure, decrease the dosage and/or number of antihypertensive medications, lower serum aldosterone, and correct hypokalemia. In the Primary Aldosteronism Surgical Outcome study, unilateral adrenalectomy had an average clinical success rate of 37%, defined as normotension in the absence of antihypertensive medication with an additional 47% of individuals with partial clinical success. 7 Conversely, in cases of bilateral adrenal hyperplasia, adrenalectomy results in low cure rates (19%), and therefore medical management is the standard of care. 4 The current recommended test for subtype classification of aldosteronism is adrenal vein sampling (AVS), but adrenal imaging is also useful for diagnosis. Compared with AVS, current protocols for computed tomography (CT) have a discordance rate of ~40%. 8,9 However, AVS is technically challenging, non-standardized, and is restricted to specialty centers. Moreover, AVS is an invasive procedure with moderate risk for hematoma or adrenal hemorrhage. Therefore, AVS is recommended only after biochemical confirmation of primary aldosteronism. 4 Imaging is important to exclude rare cases of adrenal carcinoma and for preparation for AVS. Adrenal imaging may also be beneficial to diagnose cases of primary aldosteronism with a high clinical pretest probability based on screening but negative confirmatory tests, or in cases where AVS is technically unsuccessful, such as due to failure to cannulate the right adrenal vein. 8 In these cases, non-invasive imaging that demonstrates the presence or absence of adrenal lesions may influence treatment. Moreover, the SPARTACUS trial that compared AVS vs. adrenal CT has re-kindled the debate about the role of diagnostic modalities in the management of primary aldosteronism. [10] [11] [12] For patients diagnosed with bilateral adrenal disease by AVS, more sensitive imaging modalities may also shed light on the classification of aldosteronism by distinguishing hyperplasia from multiple, small bilateral adenomas undetectable by conventional imaging.
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To improve the accuracy to detect adrenal adenomas or nodular hyperplasia, we developed a novel high-resolution magnetic resonance imaging (MRI) protocol that uses dynamic contrast enhancement and diffusion-weighted imaging (DWI). We hypothesized that the application of these techniques that enhance spatial and temporal resolution would enable detection of aldosterone-producing lesions not observed by conventional methods. We describe four individuals with primary aldosteronism with contemporaneous, negative CTs that were found to have adrenal lesions by MRI. designed and optimized for a GE MR750 3T scanner; however, the underlying techniques can be adapted to all major vendors. We have performed this protocol on multiple MRI scanners, with similar hardware and software configuration. Aspects of the protocol specifically adapted for imaging of the adrenal glands include:
1. Axial DWI with a zoomed imaging technique. This feature, adapted from prostate MRI, 13 allows for imaging only a small region, but at higher spatial resolution of 2.1 mm with a slice thickness of 4.0 mm. In contrast, conventional MRI uses a spatial resolution of 5.0 mm with a slice thickness of 7.0 mm. 2. Volumetric dynamic contrast enhanced imaging, which we tailored with a view-sharing technique that offers both high spatial resolution and frame rate to capture contrast enhancement dynamics with 8 post-contrast images. This technique is helpful in detecting adrenal nodules that enhance just shortly before the rest of the adrenal gland. The in-plane imaging matrix is 320 × 224 pixels with a slice thickness of 2.2 mm and a frame rate of 6 seconds. In contrast, conventional volumetric imaging is often performed with a slice thickness of 4.4 mm with a frame rate of 12 seconds.
The protocol also incorporates the standard technique of axial T1-weighted in and opposed phase imaging and axial T2-weighted imaging. Lastly, the protocol includes a non-contrast magnetic resonance angiogram to ensure a comprehensive hypertension work-up.
We then retrospectively evaluated the medical record of patients who had biochemical confirmation for aldosteronism without adrenal lesions by CT imaging, performed within the preceding 6 months. The CT imaging utilized a dedicated adrenal protocol with a slice thickness of ≤3.0 mm and/or multiplanar reconstructions through the adrenal glands. The Institutional Review Board at Stanford University approved the study protocol, including a waiver of informed consent for this study.
RESULTS
Patient ages ranged between 36 and 77 years at presentation, and subjects took an average of 3.0 antihypertensive medications. Each of the 4 subjects had at least 1 adrenal nodule detected by our high-resolution MRI (Tables 1 and 2 ). Following these positive MRI results, the patients underwent AVS, and all 4 of the cases had lateralization of aldosterone production (Table 1 and 2). The left adrenal vein of patient 2 was not successfully cannulated but based on the striking lateralization to the left and an informed discussion of risks and benefits, the patient was recommended for surgery. These 4 subjects underwent laparoscopic adrenalectomy with a histologic diagnosis of an APA or micronodular hyperplasia. Per consensus guidelines, 7 all 4 patients had biochemical success and partial or complete clinical success at ≥3 months post-operatively. These patients also demonstrated reduced circulating aldosterone and normokalemia. One patient was able to discontinue their antihypertensive medications entirely and one with co-existent stage 4 chronic kidney disease was able to decrease from 3 to just 1 antihypertensive agent (Table 3) .
DISCUSSION
In this case series, we report an adrenal gland-dedicated, high-resolution MRI protocol for detecting lesions in individuals with primary aldosteronism. Some of the important features of the protocol include high-resolution thin slices and contrast enhancement over multiple time points. These features specifically enabled the detection of a small <1 cm adenoma that was not shown on CT in the same individual 6 months prior (Figure 1a ) despite a 10-year antecedent history of hypertension and hypokalemia. Another unique capability of MRI is the detection of contrast-enhancing lesions that do not change the contour of the adrenal glands. The dynamic enhancement feature Table 3 . Blood pressure and antihypertensive medications pre-and post-adrenalectomy Abbreviations: Aldo, aldosterone (ng/dl); ARR, aldosterone-to-renin ratio (ng/dl per ng/ml/h); K, potassium (mmol/l); ND, not done (not able to calculate); PRA, plasma renin activity (ng/ml/h). of the MRI protocol was critical in detecting multifocal nodularity (Figure 1b) . This feature has previously been described in the detection of small contour non-deforming pancreatic neoplasms. 14 MRI can also further characterize adrenal lesions with DWI. A prior study evaluating the use of DWI in determining subtype of adrenal neoplasms has shown that DWI can serve as an adjunct in differentiating between malignant and benign lesions. 15 By detection of nodules in individuals with negative CT, more sensitive imaging modalities such as this MRI protocol may be useful, alone, or in conjunction with AVS, for clinical decision-making, or for classification of primary aldosteronism.
Adrenalectomy offers several potential advantages over medical therapy. In addition to a reduced medication burden, cost effectiveness, and improvement in quality of life, adrenalectomy results in a more favorable metabolic profile. 4, [16] [17] [18] Individuals who undergo adrenalectomy have a lower rate of diabetes compared with those treated with mineralocorticoid receptor antagonist therapy. 19 APAs also demonstrate clinically significant excess production of glucocorticoids compared with controls, and these glucocorticoids, and not the production of mineralocorticoids, correlate with several metabolic parameters including body mass index, waist circumference, high-density lipoprotein cholesterol, and insulin resistance. 18 Taken together, these data are consistent with favorable clinical sequelae for adrenalectomy versus lifelong mineralocorticoid therapy. Thus, more sensitive, yet non-invasive imaging studies may assist in the work-up for APAs over empiric use of mineralocorticoid receptor antagonism.
There are limitations of imaging compared with AVS for diagnosis of the subtype of primary aldosteronism, 9, 20 and further studies are required to determine the utility of this novel form of MRI. We cared for patients with primary aldosteronism, negative CT and MRI, and non-lateralized aldosterone secretion. This MRI protocol if implemented more broadly may also detect "incidentalomas" (nonfunctional adenomas) and could lead to unnecessary, invasive AVS or other procedures. Thus, a larger cohort is needed to determine the sensitivity and specificity of MRI. The cost and availability of MRI can limit its use compared with CT; however, the cost of screening for adenoma may be offset by the downstream reductions in cardiovascular events and improvements in quality of life. A recent decision analytic model suggested that screening individuals with resistant hypertension with CT followed by AVS was cost effective, 16 and a similar study would be needed for MRI. On the other hand, MRI limits radiation exposure and ionic contrast medium required for adrenal-dedicated CT imaging. Therefore, these cases motivate further work on the role of MRI in the diagnostic work-up of primary aldosteronism.
This case series provides proof-of-concept for the potential use of MRI with a novel, high-resolution, dynamic protocol to more accurately identify individuals amenable to potential surgical cure rather than misdiagnosis or lifelong mineralocorticoid receptor antagonist therapy.
